Dr Boreham's Crucible: Three out of four quarters says trust your about gut about Genetic Signatures
Dr Boreham’s Crucible: Three out of four quarters says trust your about gut about Genetic Signatures
Stay updated with breaking news from John Melki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Boreham’s Crucible: Three out of four quarters says trust your about gut about Genetic Signatures
Why the Genetic Signatures (ASX:GSS) share price is edging higher Aaron Teboneras | January 27, 2021 2:36pm | More on: The Genetic Signatures Ltd(ASX: GSS) share price is edging higher today. This comes after the company announced that it received CE-IVD registration for its 3base EasyScreen sexually transmitted infection (STI) Genital Pathogen Detection Kit. CE-IVD refers to an approved CE Marking from the European Union for an in vitro diagnostic (IVD) device. This allows the product to be commercially sold within Europe. What’s driving the Genetic Signatures share price higher The Gen...